amgen inc. said_0 its second-quarter earnings increased more_than tenfold to $_3.9 million , or 22_cents a_share , due to increased sales of the company 's new antianemia drug for kidney patients . the thousand oaks , calif.-based biotechnology company reported a 97 %_increase in revenue to $ 42.5 million for the quarter_ended sept._30 . in the year-ago_period , amgen reported_net income of $ 320,000 , or two cents_a share , on revenue of $ 21.5_million . for the six_months , the company reported a more_than sixfold increase in earnings to $ 4.7_million , or 26_cents a_share , from $ 625,000 , or four cents_a share a year_ago . revenue_rose 77 % to $ 72.6 million , from last_year 's $ 41 million .